GENOMIC HEALTH INC's ticker is GHDX and the CUSIP is 37244C101. A total of 126 filers reported holding GENOMIC HEALTH INC in Q1 2017. The put-call ratio across all filers is 0.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2017 | $10,906,000 | -48.3% | 318,887 | -51.4% | 0.95% | +4.7% |
Q3 2017 | $21,076,000 | +96.5% | 656,786 | +99.3% | 0.91% | -4.1% |
Q2 2017 | $10,728,000 | +15.5% | 329,585 | +11.7% | 0.94% | +4.1% |
Q1 2017 | $9,288,000 | +33.1% | 294,962 | +24.3% | 0.91% | +10.7% |
Q4 2016 | $6,976,000 | +9.0% | 237,371 | +7.2% | 0.82% | -1.6% |
Q3 2016 | $6,402,000 | +19.8% | 221,354 | +7.3% | 0.83% | +6.9% |
Q2 2016 | $5,342,000 | +16.8% | 206,291 | +11.8% | 0.78% | +8.0% |
Q1 2016 | $4,572,000 | -27.3% | 184,586 | +3.3% | 0.72% | -30.7% |
Q4 2015 | $6,293,000 | +24.5% | 178,769 | -25.1% | 1.04% | +23.6% |
Q3 2015 | $5,053,000 | -9.8% | 238,797 | +18.5% | 0.84% | -3.4% |
Q2 2015 | $5,599,000 | +13.3% | 201,490 | +24.5% | 0.87% | +12.7% |
Q1 2015 | $4,943,000 | +2.5% | 161,796 | +7.2% | 0.77% | -5.5% |
Q4 2014 | $4,824,000 | +53.2% | 150,896 | +35.6% | 0.82% | +23.9% |
Q3 2014 | $3,149,000 | +15.3% | 111,244 | +11.6% | 0.66% | +21.3% |
Q2 2014 | $2,731,000 | – | 99,669 | – | 0.54% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Camber Capital Management LP | 2,000,000 | $56,620,000 | 5.32% |
Baker Brothers Advisors | 13,655,618 | $386,590,000 | 4.87% |
NORTH TIDE CAPITAL, LLC | 1,500,000 | $42,465,000 | 3.24% |
Murphy Michael R | 291,292 | $8,246,000 | 2.85% |
Tributary Capital Management, LLC | 111,244 | $3,149,000 | 0.66% |
Champlain Investment Partners, LLC | 1,234,780 | $34,957,000 | 0.61% |
IRONBRIDGE CAPITAL MANAGEMENT LP | 454,085 | $12,855,000 | 0.34% |
STONEBRIDGE CAPITAL MANAGEMENT INC | 27,180 | $769,000 | 0.30% |
Motley Fool Asset Management LLC | 36,179 | $1,139,000 | 0.24% |
Kimelman & Baird, LLC | 35,800 | $1,013,000 | 0.19% |